Virtu Financial’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Buy
+14,356
New +$10.2K ﹤0.01% 1439
2024
Q2
Sell
-604
Closed -$31K 1645
2024
Q1
$31K Buy
+604
New +$38.4K ﹤0.01% 1100
2023
Q1
Sell
-54
Closed -$16K 1836
2022
Q4
$16K Buy
+54
New +$18.4K ﹤0.01% 1306
2022
Q3
Sell
-177
Closed -$78K 2013
2022
Q2
$78K Buy
177
+156
+743% +$86.4K 0.01% 1000
2022
Q1
$16K Sell
21
-6
-22% -$4.93K ﹤0.01% 1323
2021
Q4
$34K Buy
+27
New +$43.6K ﹤0.01% 1422
2021
Q3
Sell
-156
Closed -$389K 1770
2021
Q2
$389K Buy
156
+65
+71% +$159K 0.04% 590
2021
Q1
$227K Sell
91
-159
-64% -$473K 0.02% 1005
2020
Q4
$710K Buy
250
+206
+468% +$492K 0.08% 329
2020
Q3
$105K Buy
+44
New +$108K 0.02% 712

Other funds holding MBIO

Virtu Financial's MBIO Position: Q2 2026 in Review

Virtu Financial opened a new position in Mustang Bio (MBIO) in Q2 2026: 14,356 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings. This is a return to the name: Virtu Financial previously reported a position in MBIO as recently as Q1 2024.

Virtu Financial first reported a position in MBIO in Q3 2020 and has held it in 10 quarters since. The position peaked at $710K in Q4 2020. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • Virtu Financial held 14,356 shares of Mustang Bio worth $10K as of Q2 2026.
  • Mustang Bio was a new Virtu Financial position in Q2 2026.
  • Mustang Bio made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1439 holding.
  • Virtu Financial first reported a position in Mustang Bio in Q3 2020 and has held it in 10 quarters since.
  • Virtu Financial's Mustang Bio position peaked at $710K in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.